Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sophia C. Mort, Sebastián R. Díaz & Elizabeth A. Beverly. (2021) Using contact-based education to destigmatize opioid use disorder among medical students. Teaching and Learning in Medicine 33:2, pages 196-209.
Read now
Read now
Adam J Carinci. (2020) Abuse-Deterrent Opioid Analgesics: A Guide for Clinicians. Pain Management 10:1, pages 55-62.
Read now
Read now
Eric R. Kinzler, Carmela Pantaleon, Matthew S. Iverson & Stefan Aigner. (2019) Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation. The American Journal of Drug and Alcohol Abuse 45:4, pages 377-384.
Read now
Read now
Sandeep Sarabu, Suresh Bandari, Venkata Raman Kallakunta, Roshan Tiwari, Hemlata Patil & Michael A Repka. (2019) An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Expert Opinion on Drug Delivery 16:6, pages 567-582.
Read now
Read now
Jeremy A Adler & Theresa Mallick-Searle. (2018) An overview of abuse-deterrent opioids and recommendations for practical patient care. Journal of Multidisciplinary Healthcare 11, pages 323-332.
Read now
Read now
Martin E Hale, Derek Moe, Mary Bond, Maciej Gasior & Richard Malamut. (2016) Abuse-Deterrent Formulations of Prescription Opioid Analgesics in the Management of Chronic Noncancer Pain. Pain Management 6:5, pages 497-508.
Read now
Read now
Articles from other publishers (62)
Siddhi Surawkar. 2023. The Role of Health Literacy in Major Healthcare Crises. The Role of Health Literacy in Major Healthcare Crises
227
246
.
Kevin R. Coffey, William B. Nickelson, Aliyah J. Dawkins & John F. Neumaier. (2023) Rapid appearance of negative emotion during oral fentanyl self‐administration in male and female rats. Addiction Biology 28:12.
Crossref
Crossref
Maraya N Camazine, Kaitlyn M Rountree, Jamie B Smith, Jonathan Bath & Todd R Vogel. (2022) Opioid utilization after lower extremity amputation for peripheral vascular disease and discharge prescribing recommendations. Vascular 31:5, pages 954-960.
Crossref
Crossref
Guohui Li, Shuwen Yue, Yunwanbin Wang, Archana Singh & Zi-Jun Wang. (2023) IGF-1 Microinjection in the Prefrontal Cortex Attenuates Fentanyl-Seeking Behavior in Mice. International Journal of Neuropsychopharmacology 26:5, pages 359-371.
Crossref
Crossref
Susan M. Cibulsky, Timo Wille, Renée Funk, Danny Sokolowski, Christine Gagnon, Marc Lafontaine, Carol Brevett, Rabih Jabbour, Jessica Cox, David R. Russell, David A. Jett, Jerry D. Thomas & Lewis S. Nelson. (2023) Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids. Frontiers in Public Health 11.
Crossref
Crossref
Lydia R. MaurerMohamad El MohebElena CavalloDonna M. AntonelliPamela LinovSarah BirdHeather R. FaulknerMarcela del Carmen, Motaz QadanCristina R. FerroneHaytham M. A. KaafaraniRachel SisodiaDan B. Ellis. (2023) Enhanced Recovery After Surgery Patients Are Prescribed Fewer Opioids at Discharge. Annals of Surgery 277:2, pages e287-e293.
Crossref
Crossref
Mir M. Ali, Chandler McClellan, Ryan Mutter & Daniel I. Rees. (2022) Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata. Health Economics 32:2, pages 277-301.
Crossref
Crossref
Xin Feng, Kai-Wei Wu, Vishnu Balajee, Jesse Leissa, Muhammad Ashraf & Xiaoming Xu. (2023) Understanding syringeability and injectability of high molecular weight PEO solution through time-dependent force-distance profiles. International Journal of Pharmaceutics 631, pages 122486.
Crossref
Crossref
Golam Kibria, Bandaranayake Bandaranayake, Jiwen Zheng, Sau Lee & Celia Cruz. (2023) Stability of Abuse-deterrent properties of PEO-based Abuse-deterrent formulation. International Journal of Pharmaceutics 631, pages 122430.
Crossref
Crossref
Allyson L. Spence, Peter S. Cogan, Bianca B. Calderon, Alan David Kaye & Kailey L. Potthoff. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
185
208
.
Ram Kandasamy & Stevan Pecic. 2023. Neurobiology and Physiology of the Endocannabinoid System. Neurobiology and Physiology of the Endocannabinoid System
175
187
.
Anastasiia Vasiukhina, Sheryhan F. Gad, Elyssia N. Wellington, Danielle M. Wilmes, Yoon Yeo & Luis Solorio. (2022) PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking. International Journal of Pharmaceutics 626, pages 122151.
Crossref
Crossref
Kristen N. Amico, Miranda E. Arnold, Morgan S. Dourron, Matthew G. Solomon & Jesse R. Schank. (2022) The effect of concurrent access to alcohol and oxycodone on self-administration and reinstatement in rats. Psychopharmacology 239:10, pages 3277-3286.
Crossref
Crossref
Bojan B. Lalovic, Laura Shireman, Danny D. Shen & Monique M. Cherrier. (2022) Model‐Based Analysis of the Influence of Alcohol Use and Age on Pharmacokinetics‐Pharmacodynamics of Oral Oxycodone in Middle‐Age and Older Community‐Dwelling Adults. The Journal of Clinical Pharmacology 62:9, pages 1177-1190.
Crossref
Crossref
Chris O'Brien, Roshni Vemireddy, Uzma Mohammed & David J. Barker. (2022) Stress reveals a specific behavioral phenotype for opioid abuse susceptibility. Journal of the Experimental Analysis of Behavior 117:3, pages 518-531.
Crossref
Crossref
Vishakh Iyer, Taylor J. Woodward, Romario Pacheco & Andrea G. Hohmann. (2022) A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference. Neuropharmacology 205, pages 108925.
Crossref
Crossref
Vasantha K. Kumar. 2022. Handbook on Opium. Handbook on Opium
181
203
.
Ankit Soni, Anuja Paprikar & Senshang Lin. (2021) Effect of alkalizing agent on abuse deterrent potential of multiple-unit ingestion of bilayer abuse-deterrent extended-release tablets using propranolol as model drug for opioids overdose crisis. International Journal of Pharmaceutics 600, pages 120480.
Crossref
Crossref
Duilio Balsamo, Paolo Bajardi, Alberto Salomone & Rossano Schifanella. (2021) Patterns of Routes of Administration and Drug Tampering for Nonmedical Opioid Consumption: Data Mining and Content Analysis of Reddit Discussions. Journal of Medical Internet Research 23:1, pages e21212.
Crossref
Crossref
Mir M. Ali, Chandler B McClellan, Ryan Mutter & Daniel I. Rees. (2021) Recreational Marijuana Laws and the Use of Opioids: Evidence from Nsduh Microdata. SSRN Electronic Journal.
Crossref
Crossref
John R. Brown, GYeon Oh, Yanning Wang, Svetla Slavova, Chris Delcher, Nabarun Dasgupta & Patricia R. Freeman. (2020) Variation in Abuse‐Deterrent Formulation Opioid Prescribing in California, Florida, and Kentucky in 2018. The Journal of Rural Health 37:1, pages 23-28.
Crossref
Crossref
Sam A. McConnell, Adam J. Brandner, Brandon A. Blank, David N. Kearns, George F. Koob, Leandro F. Vendruscolo & Brendan J. Tunstall. (2021) Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration. Neuropharmacology 182, pages 108355.
Crossref
Crossref
Kanishka Rajput & Nalini Vadivelu. (2021) Acute Pain Management of Chronic Pain Patients in Ambulatory Surgery Centers. Current Pain and Headache Reports 25:1.
Crossref
Crossref
Alysabeth G. Phillips, Dillon J. McGovern, Soo Lee, Kyu Ro, David T. Huynh, Sophie K. Elvig, Katelynn N. Fegan & David H. Root. (2019) Oral prescription opioid‐seeking behavior in male and female mice. Addiction Biology 25:6.
Crossref
Crossref
Arun Butreddy, Sandeep Sarabu, Nagireddy Dumpa, Suresh Bandari & Michael A. Repka. (2020) Extended release pellets prepared by hot melt extrusion technique for abuse deterrent potential: Category-1 in-vitro evaluation. International Journal of Pharmaceutics 587, pages 119624.
Crossref
Crossref
Francisco A. Montiel Ishino, Tamika Gilreath & Faustine Williams. (2020) Finding the Hidden Risk Profiles of the United States Opioid Epidemic: Using a Person-Centered Approach on a National Dataset of Noninstitutionalized Adults Reporting Opioid Misuse. International Journal of Environmental Research and Public Health 17:12, pages 4321.
Crossref
Crossref
Malek H. Bouzaher & Thomas K. Miller. (2020) Proper Disposal of Prescription Opioids in Southwest Virginia: Assessment of Patient, Physician, and Medical Student Beliefs and Practices. Journal of Public Health Management and Practice 26:3, pages 259-269.
Crossref
Crossref
Lynn Webster & William K Schmidt. (2020) Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach. Pain Medicine 21:5, pages 992-1004.
Crossref
Crossref
Ying Jiang, Kevin S. Murnane, Bruce E. Blough & Ajay K. Banga. (2020) Transdermal Delivery of the Free Base of 3-Fluoroamphetamine: In Vitro Skin Permeation and Irritation Potential. AAPS PharmSciTech 21:3.
Crossref
Crossref
Sogra F. Barakh Ali, Sathish Dharani, Hamideh Afrooz, Eman M. Mohamed, Phillip Cook, Mansoor A. Khan & Ziyaur Rahman. (2020) Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate. AAPS PharmSciTech 21:3.
Crossref
Crossref
Cristina Miliano, E. Reilly Scott, Laura B. Murdaugh, Emma R. Gnatowski, Christine L. Faunce, Megan S. Anderson, Malissa M. Reyes, Ann M. Gregus & Matthew W. Buczynski. (2020) Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems. Journal of Neuroscience Methods 330, pages 108458.
Crossref
Crossref
Samaneh Alaei, Niloofar Babanejad, Rand Ahmad & Hamid Omidian. 2020. Engineering Drug Delivery Systems. Engineering Drug Delivery Systems
185
202
.
Marie Shigematsu-Locatelli, Takashi Kawano, Tsuyoshi Koyama, Hideki Iwata, Atsushi Nishigaki, Bun Aoyama, Hiroki Tateiwa, Noriko Kitaoka & Masataka Yokoyama. (2019) Therapeutic experience with tramadol for opioid dependence in a patient with chronic low back pain: a case report. JA Clinical Reports 5:1.
Crossref
Crossref
Haytham M. A. Kaafarani, Ahmed I. Eid, Donna M. Antonelli, David C. Chang, Ahmed E. Elsharkawy, Joana Abed Elahad, Elizabeth A. Lancaster, John T. Schulz, Serguei I. Melnitchouk, William V. Kastrinakis, Matthew M. Hutter, Peter T. Masiakos, Amy S. Colwell, Cameron D. Wright & Keith D. Lillemoe. (2019) Description and Impact of a Comprehensive Multispecialty Multidisciplinary Intervention to Decrease Opioid Prescribing in Surgery. Annals of Surgery 270:3, pages 452-462.
Crossref
Crossref
Christopher A. Blackwood, Michael Leary, Aaron Salisbury, Michael T. McCoy & Jean Lud Cadet. (2019) Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving. Neuroscience 415, pages 173-183.
Crossref
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud & Christopher P. Holstege. (2019) Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers. Drug and Alcohol Dependence 202, pages 115-122.
Crossref
Crossref
Ying Jiang, Kevin S. Murnane, Sonalika A. Bhattaccharjee, Bruce E. Blough & Ajay K. Banga. (2019) Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications. The AAPS Journal 21:4.
Crossref
Crossref
Anna Externbrink, Satish Sharan, Dajun Sun, Wenlei Jiang, David Keire & Xiaoming Xu. (2019) An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing. International Journal of Pharmaceutics 561, pages 305-313.
Crossref
Crossref
Hestia Moningka, Sarah Lichenstein, Patrick D. Worhunsky, Elise E. DeVito, Dustin Scheinost & Sarah W. Yip. (2018) Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research. Neuropsychopharmacology 44:2, pages 259-273.
Crossref
Crossref
Matthew S. Ellis, Theodore J. Cicero, Richard C. Dart & Jody L. Green. (2018) Understanding multi‐pill ingestion of prescription opioids: Prevalence, characteristics, and motivation. Pharmacoepidemiology and Drug Safety 28:1, pages 117-121.
Crossref
Crossref
Elyse M. Cornett, Rebecca Budish, Dustin Latimer, Brendon Hart, Richard D. Urman & Alan David Kaye. (2018) Management of Challenging Pharmacologic Issues in Chronic Pain and Substance Abuse Disorders. Anesthesiology Clinics 36:4, pages 615-626.
Crossref
Crossref
Ahmed I. Eid, Christopher DePesa, Ask T. Nordestgaard, Napaporn Kongkaewpaisan, Jae Moo Lee, Manasnun Kongwibulwut, Kelsey Han, April Mendoza, Martin Rosenthal, Noelle Saillant, Jarone Lee, Peter Fagenholz, David King, George Velmahos & Haytham M.A. Kaafarani. (2018) Variation of Opioid Prescribing Patterns among Patients undergoing Similar Surgery on the Same Acute Care Surgery Service of the Same Institution: Time for Standardization?. Surgery 164:5, pages 926-930.
Crossref
Crossref
Brandon E. Earp, Jacob A. Silver, Ariana N. Mora & Philip E. Blazar. (2018) Implementing a Postoperative Opioid-Prescribing Protocol Significantly Reduces the Total Morphine Milligram Equivalents Prescribed. Journal of Bone and Joint Surgery 100:19, pages 1698-1703.
Crossref
Crossref
Stephen F Butler, Ryan A Black & Alison B Fleming. (2018) Relative Abuse of Crush-Resistant Prescription Opioid Tablets via Alternative Oral Modes of Administration. Pain Medicine 19:8, pages 1613-1627.
Crossref
Crossref
Mary Bond, Kerri A Schoedel, Laura Rabinovich-Guilatt, Maciej Gasior, William Tracewell, Richard Malamut, Yuju Ma & Lynn R Webster. (2018) Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users. Pain Medicine 19:8, pages 1597-1612.
Crossref
Crossref
Aaron J. Salwan, Nicholas E. Hagemeier & Sam Harirforoosh. (2018) Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?. Clinical Drug Investigation 38:7, pages 573-577.
Crossref
Crossref
Abigail Brooks & Courtney Kominek. (2018) ADF: Abuse-Deterrent Formulation or Another Disillusioned Formulation?. Pain Medicine 19:5, pages 907-909.
Crossref
Crossref
Farah A. HusainHarris W. HollisJr.Jr., Brian J. PottorfJames L. RogersScott M. GolembeskiJason M. Johnson. (2018) The Effect of Transoral Gastric Remnant Extraction on Prescription Opioid Refills and Surgical Site Infections in Patients Undergoing Sleeve Gastrectomy. Bariatric Surgical Practice and Patient Care 13:1, pages 12-17.
Crossref
Crossref
Janaina C M Vendruscolo, Brendan J Tunstall, Stephanie A Carmack, Brooke E Schmeichel, Emily G Lowery-Gionta, Maury Cole, Olivier George, Sophia A Vandewater, Michael A Taffe, George F Koob & Leandro F Vendruscolo. (2017) Compulsive-Like Sufentanil Vapor Self-Administration in Rats. Neuropsychopharmacology 43:4, pages 801-809.
Crossref
Crossref
Lynn R. Webster, Carmela Pantaleon, Matthew Iverson, Michael D. Smith, Eric R. Kinzler & Stefan Aigner. (2018) Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects. Pain Research and Management 2018, pages 1-10.
Crossref
Crossref
Annetta M. Madsen, Lauren M. Stark, Phinnara Has, Jenna B. Emerson, Jay Schulkin & Kristen A. Matteson. (2018) Opioid Knowledge and Prescribing Practices Among Obstetrician–Gynecologists. Obstetrics & Gynecology 131:1, pages 150-157.
Crossref
Crossref
Justin G. Kullgren, Amar P. Thakkar & Michael G. O’Neil. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
135
139
.
M. Margarita Murphy. 2018. Hemorrhoids. Hemorrhoids
451
459
.
Theresa A. Cassidy, Natasha Oyedele, Travis C. Mickle, Sven Guenther & Simon H. Budman. (2017) Patterns of abuse and routes of administration for immediate‐release hydrocodone combination products. Pharmacoepidemiology and Drug Safety 26:9, pages 1071-1082.
Crossref
Crossref
Ryann O'Neill, Kimberly Lor & Jennifer Pruskowski. (2017) Abuse-Deterrent Opioid Formulations #329. Journal of Palliative Medicine 20:6, pages 676-678.
Crossref
Crossref
Natalie Thurtle, Rachelle Abouchedid, John R. H. Archer, James Ho, Takahiro Yamamoto, Paul I. Dargan & David M. Wood. (2016) Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London. Journal of Medical Toxicology 13:1, pages 61-65.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Leandro Lumermann, Thomas Suchy, Matthew M. Burg & Manuel L. Fontes. (2017) Management of Patients on Abuse-Deterrent Opioids in the Ambulatory Surgery Setting. Current Pain and Headache Reports 21:2.
Crossref
Crossref
Ziyaur Rahman, Ahmed S. Zidan, Maxwell Korang-Yeboah, Yang Yang, Akhtar Siddiqui, Diaa Shakleya, Mansoor A. Khan, Celia Cruz & Muhammad Ashraf. (2017) Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets. International Journal of Pharmaceutics 517:1-2, pages 303-311.
Crossref
Crossref
M. Murphy. 2017. Hemorrhoids. Hemorrhoids
1
9
.
Yvette N. Lamb, Karly P. Garnock-Jones & Susan J. Keam. (2016) Oxycodone DETERx® ER Capsules: A Review in Severe, Chronic Pain. Drugs 76:18, pages 1759-1769.
Crossref
Crossref
Laxmaiah Manchikanti, Adam M. Kaye & Alan D. Kaye. (2016) Current State of Opioid Therapy and Abuse. Current Pain and Headache Reports 20:5.
Crossref
Crossref
R. Grandhe, D. Souzdalnitski & K. Gritsenko. (2016) New Chronic Pain Treatments in the Outpatient Setting: Review Article. Current Pain and Headache Reports 20:5.
Crossref
Crossref